Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.
Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
As global citizens, we work sustainably, responsibly and seek to give back. Through the Bristol-Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
머크는 헬스케어, 생명과학, 기능성 소재 분야에서 과학과 기술을 선도하는 기업입니다. 암과 다발성 신경 경화증을 치료하기 위한 바이오 제약 치료요법부터 과학적인 연구와 생산을 위한 첨단 시스템, 스마트폰과 LCD TV용 액정에 이르기까지 약 5만 명의 직원들이 삶을 더 풍요롭게 하고 그 가치를 더 높이는 기술을 개발하기 위해 일하고 있습니다.
머크는 1668년에 설립된 세계에서 가장 오래된 역사를 가진 제약 및 화학 회사입니다.
현재 창립가문이 회사의 주요 주주로 대부분의 회사 주식을 소유하고 있습니다. 독일 다름슈타트에 본사를 둔 머크는 전세계적으로 머크라는 상호와 브랜드를 사용할 권리를 가지고 있습니다. 유일한 예외가 있다면 캐나다와 미국이며, 그 곳에서는 회사가 EMD 세로노, 밀리포어시그마, EMD 기능성 소재 사업부로 운영됩니다.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.